Abstract:Natural products are a major source of biologically active compounds that make promising lead molecules for developing efficacious drug-like molecules. Natural withanolides are found in many flora and fauna, including plants, algae, and corals, that traditionally have shown multiple health benefits and are known for their anti-cancer, anti-inflammatory, anti-bacterial, anti-leishmaniasis, and many other medicinal properties. Structures of these withanolides possess a few reactive sites that can be exploited to… Show more
“…The bioactive compound withaferin A is a steroidal lactone primarily extracted from W. somnifera , first isolated by Israeli chemists, Asher Lavie and David Yarden, in 1962 from the leaves of the plant. The inhibitory properties of the withaferin A molecule are due to the occurrence of an unsaturated lactone in a side chain; allylic 1° alcohol is attached at position 25 and the highly oxygenated rings A and B are attached to the other side of the compound [ 32 , 33 , 34 , 35 , 36 ]. Cytotoxicity is achieved by the presence of α,β-unsaturated carbonyl moiety of the withaferin A structure of thiol adducts [ 37 ].…”
Cancer represents the second most deadly disease and one of the most important public health concerns worldwide. Surgery, chemotherapy, radiation therapy, and immune therapy are the major types of treatment strategies that have been implemented in cancer treatment. Unfortunately, these treatment options suffer from major limitations, such as drug-resistance and adverse effects, which may eventually result in disease recurrence. Many phytochemicals have been investigated for their antitumor efficacy in preclinical models and clinical studies to discover newer therapeutic agents with fewer adverse effects. Withaferin A, a natural bioactive molecule isolated from the Indian medicinal plant Withania somnifera (L.) Dunal, has been reported to impart anticancer activities against various cancer cell lines and preclinical cancer models by modulating the expression and activity of different oncogenic proteins. In this article, we have comprehensively discussed the biosynthesis of withaferin A as well as its antineoplastic activities and mode-of-action in in vitro and in vivo settings. We have also reviewed the effect of withaferin A on the expression of miRNAs, its combinational effect with other cytotoxic agents, withaferin A-based formulations, safety and toxicity profiles, and its clinical potential.
“…The bioactive compound withaferin A is a steroidal lactone primarily extracted from W. somnifera , first isolated by Israeli chemists, Asher Lavie and David Yarden, in 1962 from the leaves of the plant. The inhibitory properties of the withaferin A molecule are due to the occurrence of an unsaturated lactone in a side chain; allylic 1° alcohol is attached at position 25 and the highly oxygenated rings A and B are attached to the other side of the compound [ 32 , 33 , 34 , 35 , 36 ]. Cytotoxicity is achieved by the presence of α,β-unsaturated carbonyl moiety of the withaferin A structure of thiol adducts [ 37 ].…”
Cancer represents the second most deadly disease and one of the most important public health concerns worldwide. Surgery, chemotherapy, radiation therapy, and immune therapy are the major types of treatment strategies that have been implemented in cancer treatment. Unfortunately, these treatment options suffer from major limitations, such as drug-resistance and adverse effects, which may eventually result in disease recurrence. Many phytochemicals have been investigated for their antitumor efficacy in preclinical models and clinical studies to discover newer therapeutic agents with fewer adverse effects. Withaferin A, a natural bioactive molecule isolated from the Indian medicinal plant Withania somnifera (L.) Dunal, has been reported to impart anticancer activities against various cancer cell lines and preclinical cancer models by modulating the expression and activity of different oncogenic proteins. In this article, we have comprehensively discussed the biosynthesis of withaferin A as well as its antineoplastic activities and mode-of-action in in vitro and in vivo settings. We have also reviewed the effect of withaferin A on the expression of miRNAs, its combinational effect with other cytotoxic agents, withaferin A-based formulations, safety and toxicity profiles, and its clinical potential.
“…The multifaceted activities of oxiranes and their derivatives in terms of anti-microbial, anti-cancer, and anti-tumor have been investigated by bio-chemists and chemists. [1][2][3][4][5] For synthesis of oxiranes from chalcones and alkenes, numerous reagents and catalysts have been utilized. 6 These epoxides are exible chemicals that can easily undergo stereospecic ring-opening reactions to generate multifunctional molecules.…”
In this study, (2-propoxyphenyl)(3-(p-tolyl)oxiran-2-yl)methanone was synthesised by oxidizing the double bond of the respective chalcone via the Weitz–Scheffer epoxidation reaction. The insecticidal activities of the newly synthesized compounds were tested with computional investigation.
“…Alternatively, development of novel and sensitive techniques to detect biologically active PBNPs, advanced techniques to isolate, purify and structurally characterize PBNPs, and advances to meet out demand-supply aspects of PBNPs have prompted interest in development and promotion of herbal drugs. In recent years, both combinatorial chemistry and highthroughput screening platforms have significantly increased the number of compounds for which early data on absorption, distribution, metabolism, excretion (ADME) and toxicity (T) are not available, which has led to the development of a variety of medium and high-throughput in vitro ADMET screens for drug development and design with deeper dimension with high degree of precision taking into account cost economics and time [5][6][7][8][9][10][11][12][13][14][15][16][17][18][19] .…”
Physalis minima (PM) belongs to the family Solanaceae. PM has been traditionally used to cure and prevent several disorders as documented in Vedic Texts. Nevertheless, scientific values of traditional claims haven't been explored yet. In the previous study, GCMS analysis of P. minima ethanolic leaf extracts (PMELE) indicated the presence of Cyclobutanol (C4H8O); D-Alanine (C3H7O2N); 2-Heptanol, 6-Amino-2-Methyl (C8H19ON); 1-Pentanol, 4-Amino (C5H13NO); Benzeneethanamine, 3-Fluoro-Beta.,5-Dihydroxy-N-Methyl (C9H12FNO2) and L-Alanine, N-(N-Acetylglycyl)-, Butyl Ester (C11H20N2O4). However, biological activities of these bioactive compounds are not known which hampers the exploitation of these compounds by pharma-industries on a commercial scale. This study on ADMET, Pharmacokinetics, Drug-likeness and Medicinal Chemistry of Bioactive Compounds in PMELE aims to provide baseline information on PBNPs as a potential source of natural lead molecules for next generation drug design, development and therapeutics.
Keywords: PM-PBNPs; ADMET; PMELE; Pharmacokinetics; Drug-likeness; Drug Development; Bioactive Compounds
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.